These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 28610769)
1. Insight into the contribution of isoprostanoids to the health effects of omega 3 PUFAs. Joumard-Cubizolles L; Lee JC; Vigor C; Leung HH; Bertrand-Michel J; Galano JM; Mazur A; Durand T; Gladine C Prostaglandins Other Lipid Mediat; 2017 Nov; 133():111-122. PubMed ID: 28610769 [TBL] [Abstract][Full Text] [Related]
2. Simultaneous quantitative profiling of 20 isoprostanoids from omega-3 and omega-6 polyunsaturated fatty acids by LC-MS/MS in various biological samples. Dupuy A; Le Faouder P; Vigor C; Oger C; Galano JM; Dray C; Lee JC; Valet P; Gladine C; Durand T; Bertrand-Michel J Anal Chim Acta; 2016 May; 921():46-58. PubMed ID: 27126789 [TBL] [Abstract][Full Text] [Related]
3. Non-enzymatic cyclic oxygenated metabolites of omega-3 polyunsaturated fatty acid: Bioactive drugs? Roy J; Le Guennec JY; Galano JM; Thireau J; Bultel-Poncé V; Demion M; Oger C; Lee JC; Durand T Biochimie; 2016 Jan; 120():56-61. PubMed ID: 26112019 [TBL] [Abstract][Full Text] [Related]
4. Biological activities of non-enzymatic oxygenated metabolites of polyunsaturated fatty acids (NEO-PUFAs) derived from EPA and DHA: New anti-arrhythmic compounds? Galano JM; Roy J; Durand T; Lee JC; Le Guennec JY; Oger C; Demion M Mol Aspects Med; 2018 Dec; 64():161-168. PubMed ID: 29572110 [TBL] [Abstract][Full Text] [Related]
5. Current development in non-enzymatic lipid peroxidation products, isoprostanoids and isofuranoids, in novel biological samples. Leung KS; Galano JM; Durand T; Lee JC Free Radic Res; 2015; 49(7):816-26. PubMed ID: 25184341 [TBL] [Abstract][Full Text] [Related]
6. Lipidomic methodologies for biomarkers of chronic inflammation in nutritional research: ω-3 and ω-6 lipid mediators. Dasilva G; Medina I Free Radic Biol Med; 2019 Nov; 144():90-109. PubMed ID: 30902758 [TBL] [Abstract][Full Text] [Related]
7. Omega-3 polyunsaturated fatty acids and oxygenated metabolism in atherothrombosis. Guichardant M; Calzada C; Bernoud-Hubac N; Lagarde M; Véricel E Biochim Biophys Acta; 2015 Apr; 1851(4):485-95. PubMed ID: 25263947 [TBL] [Abstract][Full Text] [Related]
8. Non-enzymatic lipid oxidation products in biological systems: assessment of the metabolites from polyunsaturated fatty acids. Vigor C; Bertrand-Michel J; Pinot E; Oger C; Vercauteren J; Le Faouder P; Galano JM; Lee JC; Durand T J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 964():65-78. PubMed ID: 24856297 [TBL] [Abstract][Full Text] [Related]
9. Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis. Ishihara T; Yoshida M; Arita M Int Immunol; 2019 Aug; 31(9):559-567. PubMed ID: 30772915 [TBL] [Abstract][Full Text] [Related]
10. Omega-3 Polyunsaturated Fatty Acids and Their Health Benefits. Shahidi F; Ambigaipalan P Annu Rev Food Sci Technol; 2018 Mar; 9():345-381. PubMed ID: 29350557 [TBL] [Abstract][Full Text] [Related]
11. Isoprostanes and neuroprostanes: total synthesis, biological activity and biomarkers of oxidative stress in humans. Galano JM; Mas E; Barden A; Mori TA; Signorini C; De Felice C; Barrett A; Opere C; Pinot E; Schwedhelm E; Benndorf R; Roy J; Le Guennec JY; Oger C; Durand T Prostaglandins Other Lipid Mediat; 2013 Dec; 107():95-102. PubMed ID: 23644158 [TBL] [Abstract][Full Text] [Related]
12. Non-enzymatic cyclic oxygenated metabolites of adrenic, docosahexaenoic, eicosapentaenoic and α-linolenic acids; bioactivities and potential use as biomarkers. Galano JM; Lee JC; Gladine C; Comte B; Le Guennec JY; Oger C; Durand T Biochim Biophys Acta; 2015 Apr; 1851(4):446-55. PubMed ID: 25463478 [TBL] [Abstract][Full Text] [Related]
13. Omega-3 to omega-6 fatty acid oxidation ratio as a novel inflammation resolution marker for metabolic complications in obesity. Sarajlic P; Vigor C; Avignon A; Zhou B; Oger C; Galano JM; Durand T; Sultan A; Bäck M Nutr Metab Cardiovasc Dis; 2023 Jun; 33(6):1206-1213. PubMed ID: 37032252 [TBL] [Abstract][Full Text] [Related]
15. Pre-analytical monitoring and protection of oxidizable lipids in human plasma (vitamin E and ω-3 and ω-6 fatty acids): An update for redox-lipidomics methods. Torquato P; Giusepponi D; Bartolini D; Barola C; Marinelli R; Sebastiani B; Galarini R; Galli F Free Radic Biol Med; 2021 Nov; 176():142-148. PubMed ID: 34562608 [TBL] [Abstract][Full Text] [Related]
16. Long chain omega-3 fatty acids and their oxidized metabolites are associated with reduced prostate tumor growth. Bilodeau JF; Gevariya N; Larose J; Robitaille K; Roy J; Oger C; Galano JM; Bergeron A; Durand T; Fradet Y; Julien P; Fradet V Prostaglandins Leukot Essent Fatty Acids; 2021 Jan; 164():102215. PubMed ID: 33276284 [TBL] [Abstract][Full Text] [Related]
17. Chemistry and biology of ω-3 PUFA peroxidation-derived compounds. Wang W; Yang H; Johnson D; Gensler C; Decker E; Zhang G Prostaglandins Other Lipid Mediat; 2017 Sep; 132():84-91. PubMed ID: 28049021 [TBL] [Abstract][Full Text] [Related]
18. Omega-3 Fatty Acids in the Management of Epilepsy. Tejada S; Martorell M; Capó X; Tur JA; Pons A; Sureda A Curr Top Med Chem; 2016; 16(17):1897-905. PubMed ID: 26845549 [TBL] [Abstract][Full Text] [Related]